Endoscopic screening for oesophageal cancer: empowering artificial intelligence with a high-quality examination

Affiliations

Comment

Cadman L Leggett. Lancet Gastroenterol Hepatol. 2024 Jan.

. 2024 Jan;9(1):4-5.

doi: 10.1016/S2468-1253(23)00377-1. Epub 2023 Nov 10.

¹ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: leggett.cadman@mayo.edu.

No abstract available

Conflict of interest statement

I declare no competing interests.

Effect of an artificial intelligence-assisted system on endoscopic diagnosis of superficial oesophageal squamous cell carcinoma and precancerous lesions: a multicentre, tandem, double-blind, randomised controlled trial.
Yuan XL, Liu W, Lin YX, Deng QY, Gao YP, Wan L, Zhang B, Zhang T, Zhang WH, Bi XG, Yang GD, Zhu BH, Zhang F, Qin XB, Pan F, Zeng XH, Chaudhry H, Pang MY, Yang J, Zhang JY, Hu B. Yuan XL, et al. Lancet Gastroenterol Hepatol. 2024 Jan;9(1):34-44. doi: 10.1016/S2468-1253(23)00276-5. Epub 2023 Nov 10. Lancet Gastroenterol Hepatol. 2024. PMID: 37952555 Clinical Trial.